COASTAL PHARMS
GenericsCOASTAL PHARMS is a generic drug manufacturer focused on Ophthalmology.
COASTAL PHARMS's Key Drugs
COASTAL PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
COASTAL PHARMS's Recent FDA Approvals
New NDA/BLA approvals for COASTAL PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
COASTAL PHARMS's Therapeutic Areas
COASTAL PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Ophthalmology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
COASTAL PHARMS's Top Competitors
COASTAL PHARMS's closest competitors by therapeutic-area and drug-target overlap include Novartis, AbbVie, and OTSUKA ICU MEDCL. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
COASTAL PHARMS Pipeline Snapshot
Active clinical trials for COASTAL PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Ophthalmology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2011-05-11
- Latest
- 2013-01-09
- Applications
- 1